23.01.20: Not intended for U.S. and UK Media
Bayer receives approval for darolutamide in JapanMarketing authorization granted for the treatment of men with non-metastatic castration-resistant prostate cancermehr ...
Source: Bayer IR Newsfeed: Events - Category: Pharmaceuticals Source Type: news
More News: Cancer & Oncology | Pharmaceuticals